Learner Tien vs Jannik Sinner. Expert analysis, H2H stats, and robust betting predictions for the desert duel.
HARMONIA trial will assess multi-system efficacy, safety and tolerability of z-basivarsen in DM1 -- 48-week trial will enroll approximately 150 ...
Rick Barnes has been a head coach for 48 years. Won 857 games, been to the NCAA Tournament 29 times. He is not a man who needs to explain or even create a culture around his team. It sort of just ...
Dyne Therapeutics maintains a strong $1.1B cash position, funding operations into mid-2028 despite heavy R&D and operating ...
You can build real income with a laptop, AI tools, and Thailand's low cost of living. When your monthly baseline can sit around $500 to $1,600 ...
Acurx Pharmaceuticals, Inc. ("Acurx" or the "Company"), a clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, today announced ...
A key innovation of the P100 COMx6 series is SolidRun's LP-CAMM2 memory integration in an industrial COM Express Type 6 module, delivering the best of all worlds: the serviceability of modular memory ...
Advanced Global Phase 3 Program for Treatment of Hepatitis C Virus (HCV) in 2025 with Topline Results from North American C-BEYOND Trial Expected ...
What the AI jobs panic is missing.
Acurx's Program in the Broader CDI Patient Population is Ready to Advance toPhase 3 International Clinical Trials Acurx is launching a ground-breaking clinical trial ...
Good morning, everybody. My name is Kyahn Williamson, SVP of Investor Relations and Corporate Communications at Telix. And we're very pleased to welcome you today to our investor call and webcast to ...
Advanced Global Phase 3 Program for Treatment of Hepatitis C Virus (HCV) in 2025 with Topline Results from North American C-BEYOND Trial Expected Mid-2026 and Topline Results from C-FORWARD Trial Outs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results